Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing

Background/Aims: Drug resistance remains a main obstacle to the treatment of non- small cell lung cancer (NSCLC). The aim of this study was to identify the expression profiles of microRNAs (miRNAs) in drug-resistant NSCLC cell lines. Methods: The expression profiles of miRNAs in drug-resistant NSCLC...

Full description

Bibliographic Details
Main Authors: Shousen Hu, Yongliang Yuan, Zhizhen Song, Dan Yan, Xiangzhen Kong
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-12-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/495921
_version_ 1818174090280697856
author Shousen Hu
Yongliang Yuan
Zhizhen Song
Dan Yan
Xiangzhen Kong
author_facet Shousen Hu
Yongliang Yuan
Zhizhen Song
Dan Yan
Xiangzhen Kong
author_sort Shousen Hu
collection DOAJ
description Background/Aims: Drug resistance remains a main obstacle to the treatment of non- small cell lung cancer (NSCLC). The aim of this study was to identify the expression profiles of microRNAs (miRNAs) in drug-resistant NSCLC cell lines. Methods: The expression profiles of miRNAs in drug-resistant NSCLC cell lines were examined using miRNA sequencing, and the common dysregulated miRNAs in these cell lines were identified and analyzed by bioinformatics methods. Results: A total of 29 upregulated miRNAs and 36 downregulated miRNAs were found in the drug-resistant NSCLC cell lines, of which 26 upregulated and 36 downregulated miRNAs were found to be involved in the Ras signaling pathway. The expression levels, survival analysis, and receiver operating characteristic curve of the dysregulated miRNAs based on The Cancer Genome Atlas database for lung adenocarcinoma showed that hsa-mir-192, hsa-mir-1293, hsa-mir-194, hsa-mir-561, hsa-mir-205, hsa-mir-30a, and hsa-mir-30c were related to lung cancer, whereas only hsa-mir-1293 and hsa-mir-561 were not involved in drug resistance. Conclusion: The results of this study may provide novel biomarkers for drug resistance in NSCLC and potential therapies for overcoming drug resistance, and may also reveal the potential mechanisms underlying drug resistance in this disease.
first_indexed 2024-12-11T19:38:52Z
format Article
id doaj.art-b4838b29cf244cd586a88f0e0e5a24d6
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-11T19:38:52Z
publishDate 2018-12-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-b4838b29cf244cd586a88f0e0e5a24d62022-12-22T00:53:05ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-12-015162509252210.1159/000495921495921Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA SequencingShousen HuYongliang YuanZhizhen SongDan YanXiangzhen KongBackground/Aims: Drug resistance remains a main obstacle to the treatment of non- small cell lung cancer (NSCLC). The aim of this study was to identify the expression profiles of microRNAs (miRNAs) in drug-resistant NSCLC cell lines. Methods: The expression profiles of miRNAs in drug-resistant NSCLC cell lines were examined using miRNA sequencing, and the common dysregulated miRNAs in these cell lines were identified and analyzed by bioinformatics methods. Results: A total of 29 upregulated miRNAs and 36 downregulated miRNAs were found in the drug-resistant NSCLC cell lines, of which 26 upregulated and 36 downregulated miRNAs were found to be involved in the Ras signaling pathway. The expression levels, survival analysis, and receiver operating characteristic curve of the dysregulated miRNAs based on The Cancer Genome Atlas database for lung adenocarcinoma showed that hsa-mir-192, hsa-mir-1293, hsa-mir-194, hsa-mir-561, hsa-mir-205, hsa-mir-30a, and hsa-mir-30c were related to lung cancer, whereas only hsa-mir-1293 and hsa-mir-561 were not involved in drug resistance. Conclusion: The results of this study may provide novel biomarkers for drug resistance in NSCLC and potential therapies for overcoming drug resistance, and may also reveal the potential mechanisms underlying drug resistance in this disease.https://www.karger.com/Article/FullText/495921miRNAsDrug resistanceNon-small cell lung cancerhsa-mir-561hsa-mir-1293
spellingShingle Shousen Hu
Yongliang Yuan
Zhizhen Song
Dan Yan
Xiangzhen Kong
Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing
Cellular Physiology and Biochemistry
miRNAs
Drug resistance
Non-small cell lung cancer
hsa-mir-561
hsa-mir-1293
title Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing
title_full Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing
title_fullStr Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing
title_full_unstemmed Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing
title_short Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing
title_sort expression profiles of micrornas in drug resistant non small cell lung cancer cell lines using microrna sequencing
topic miRNAs
Drug resistance
Non-small cell lung cancer
hsa-mir-561
hsa-mir-1293
url https://www.karger.com/Article/FullText/495921
work_keys_str_mv AT shousenhu expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing
AT yongliangyuan expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing
AT zhizhensong expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing
AT danyan expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing
AT xiangzhenkong expressionprofilesofmicrornasindrugresistantnonsmallcelllungcancercelllinesusingmicrornasequencing